Cargando…
Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368234/ https://www.ncbi.nlm.nih.gov/pubmed/30783520 http://dx.doi.org/10.18632/oncotarget.26650 |
_version_ | 1783393948573630464 |
---|---|
author | Adamo, Barbara Ricciardi, Giuseppina Rosaria Rita Ieni, Antonio Franchina, Tindara Fazzari, Carmine Sanò, Maria Vita Angelico, Giuseppe Caruso, Michele Tuccari, Giovanni Adamo, Vincenzo |
author_facet | Adamo, Barbara Ricciardi, Giuseppina Rosaria Rita Ieni, Antonio Franchina, Tindara Fazzari, Carmine Sanò, Maria Vita Angelico, Giuseppe Caruso, Michele Tuccari, Giovanni Adamo, Vincenzo |
author_sort | Adamo, Barbara |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6368234 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-63682342019-02-19 Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer Adamo, Barbara Ricciardi, Giuseppina Rosaria Rita Ieni, Antonio Franchina, Tindara Fazzari, Carmine Sanò, Maria Vita Angelico, Giuseppe Caruso, Michele Tuccari, Giovanni Adamo, Vincenzo Oncotarget Correction Impact Journals LLC 2019-01-25 /pmc/articles/PMC6368234/ /pubmed/30783520 http://dx.doi.org/10.18632/oncotarget.26650 Text en Copyright: © 2019 Adamo et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Correction Adamo, Barbara Ricciardi, Giuseppina Rosaria Rita Ieni, Antonio Franchina, Tindara Fazzari, Carmine Sanò, Maria Vita Angelico, Giuseppe Caruso, Michele Tuccari, Giovanni Adamo, Vincenzo Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer |
title | Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer |
title_full | Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer |
title_fullStr | Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer |
title_full_unstemmed | Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer |
title_short | Correction: The prognostic significance of combined androgen receptor, E-Cadherin, Ki67 and CK5/6 expression in patients with triple negative breast cancer |
title_sort | correction: the prognostic significance of combined androgen receptor, e-cadherin, ki67 and ck5/6 expression in patients with triple negative breast cancer |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368234/ https://www.ncbi.nlm.nih.gov/pubmed/30783520 http://dx.doi.org/10.18632/oncotarget.26650 |
work_keys_str_mv | AT adamobarbara correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer AT ricciardigiuseppinarosariarita correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer AT ieniantonio correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer AT franchinatindara correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer AT fazzaricarmine correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer AT sanomariavita correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer AT angelicogiuseppe correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer AT carusomichele correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer AT tuccarigiovanni correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer AT adamovincenzo correctiontheprognosticsignificanceofcombinedandrogenreceptorecadherinki67andck56expressioninpatientswithtriplenegativebreastcancer |